BIOD351 Module 3 FINAL TEST READINESS EXAM Q & S 2026/2027

PORTAGE LEARNING
Loading...

Loading secure study material viewer...

Page 0 of 0

Document Text

BIOD351
Module 3
FINAL TEST READINESS EXAM
Q & S
©2026/2027
1. Which of the following is a common side effect of ACE
inhibitors when used in patients with chronic kidney disease
(CKD)?
 - A) Hyperkalemia
 - B) Hypocalcemia
 - C) Hypertension
 - D) Bradycardia
 - Correct Asnwer: A) Hyperkalemia
2. In managing atrial fibrillation, which class of drug is
commonly used to prevent stroke?
 - A) Diuretics
 - B) Anticoagulants
 - C) Beta-blockers
 - D) ACE inhibitors
 - Correct Asnwer: B) Anticoagulants
3. Which drug is the first-line treatment for hypertension in
a patient with diabetic nephropathy?
 - A) Thiazide diuretics
 - B) Calcium channel blockers
 - C) ACE inhibitors
 - D) Beta-blockers
 - Correct Asnwer: C) ACE inhibitors
4. Which type of heart failure is characterized by
preserved ejection fraction?
 - A) Left-sided heart failure
 - B) Right-sided heart failure
 - C) Systolic heart failure
 - D) Diastolic heart failure 

Download Study Material

Buy This Material

$35.00 One-time purchase
Buy Now
  • Full access to this material
  • Download anytime
  • No expiration

Study Material Information

Category: PORTAGE LEARNING
Description:

BIOD351 Module 3 FINAL TEST READINESS EXAM Q & S 2026/2027

Get this material $35.00